Jean-Pierre Bizzari Net Worth & Insider Trades

Jean-Pierre Bizzari - Director, Halozyme Therapeutics, Inc

As of May 6, 2022

What is Jean-Pierre Bizzari's Net Worth?

The current estimated net worth of Halozyme Therapeutics, Inc's Director, Jean-Pierre Bizzari, is estimated to be about $4.89M . Jean-Pierre Bizzari owns about 52,544 units of Halozyme Therapeutics, Inc common stock. In the last 7 years at Halozyme Therapeutics, Inc, Jean-Pierre Bizzari has sold an estimated value of $1.44M worth.

What is Jean-Pierre Bizzari's Past Insider Trading?

Jean-Pierre Bizzari's largest sale order was 35,000 units , worth over $1.44M on August 25, 2021. In total, Jean-Pierre Bizzari has made about 10 transactions over 7 years of their time at Halozyme Therapeutics, Inc. Jean-Pierre Bizzari usually trades in May, with the busiest year in 2015 and 2021.

Jean-Pierre Bizzari

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Jean-Pierre Bizzari's' Mailing Address?

  • Mailing address is 235 Laurel Ln Haverfold PA 19041 PA

Halozyme Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Helen I. Torley 2020 $791,440 - $2,500,018 $2,500,001 $712,270 $15,147 $6,518,876
Helen I. Torley 2019 $761,000 - $2,184,130 $2,184,128 $712,296 $15,572 $5,857,126
Helen I. Torley 2018 $725,000 - $2,115,640 $2,115,631 $831,665 $11,733 $5,799,669
Elaine D. Sun 2020 $395,833 $150,000 $1,500,269 $1,000,008 $180,352 $133,399 $3,359,861
Laurie D. Stelzer 2020 $93,225 - - - - $77,996 $171,221
Laurie D. Stelzer 2019 $495,000 $2,500 $750,016 $750,005 $231,660 $16,939 $2,246,120
Laurie D. Stelzer 2018 $470,000 - $575,018 $575,009 $323,489 $9,409 $1,952,925
Masaru Matsuda 2020 $440,000 $50,000 $500,019 $500,008 $203,940 $13,901 $1,707,868
Michael J. LaBarre 2020 $475,000 - $650,009 $650,007 $220,163 $15,018 $2,010,197
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1159036/000115903621000019/halodefproxy2021.htm

What are Halozyme Therapeutics, Inc's Past Insider Trades?

Halozyme Therapeutics, Inc's most recent insider trade came on March 9, 2023 by Helen Torley who sold 30,000 units worth $1.31M . In the last 16 years, insiders at Halozyme Therapeutics, Inc have sold an estimated value of $148.21M and bought an estimated value of $83.48M worth of shares. Insider trading is most common in February, with the busiest year in 2007. The most active traders at the company are Helen Torley, PRESIDENT AND CEO,  Gregory Ian Frost, CEO,  and Randal J Kirk .

HALOZYME THERAPEUTICS, INC. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...